ACQUISITIONS - Schedule of preliminary purchase consideration (Details) - Kind Therapeutics USA LLC. $ in Thousands |
1 Months Ended |
|---|---|
|
Apr. 30, 2022
USD ($)
| |
| Cash consideration: | |
| Cash paid at closing | $ 10,128 |
| Release of escrow | 2,444 |
| Severance paid from escrow | 556 |
| Less cash acquired | (2,310) |
| Net cash consideration | 10,818 |
| Note payable | 5,634 |
| Write-off accounts receivable | 658 |
| Write-off of deferred accounts receivable | 842 |
| Total fair value of consideration transferred | $ 17,952 |
| X | ||||||||||
- Definition Business Combination Cash Paid At Closing. No definition available.
|
| X | ||||||||||
- Definition Business Combination Less Cash Acquired. No definition available.
|
| X | ||||||||||
- Definition Business Combination Net Cash Consideration. No definition available.
|
| X | ||||||||||
- Definition Business Combination Note Payable. No definition available.
|
| X | ||||||||||
- Definition Business Combination Release Of Escrow. No definition available.
|
| X | ||||||||||
- Definition Business Combination Severance Paid From Escrow. No definition available.
|
| X | ||||||||||
- Definition Business Combination Writeoff Accounts Receivable. No definition available.
|
| X | ||||||||||
- Definition Business Combination Writeoff Of Deferred Accounts Receivable. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|